Mandated enrollment into a high-deductible insurance plan delays the time it takes patients with diabetes to seek care for cardiovascular (macrovascular) disease-related symptoms, tests, and procedures, compared with those who remain on a low-deductible insurance plan, an observational, longitudinal study suggests.
“High-deductible plans, which require potential out-of-pocket spending of approximately $1000 to $7000 per person per year for most nonpreventive care, have become an increasingly common feature of US commercial health insurance,” Frank Wharam, MD, MPH, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, and colleagues observe in their article, published online November 19 in the Annals of Internal Medicine.
Read more at Medscape
Research Areas
You might also be interested in...
View all News-
Does taxing sugary drinks result in better health outcomes? What some cities have found
May 24, 2025 -
Planning grants awarded for competitive proposals testing efficacy of food is medicine
May 20, 2025 -
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
April 25, 2025 -
Research Brief: Simple Visual Aids Raise Awareness and Knowledge About HIV Treatment
March 26, 2025 -
Paying Kids for Asthma Inhaler Adherence Helps, Temporarily
March 18, 2025 -
First-Of-Its-Kind Trial Shows Promise of Coordinating Child Asthma Care Across a City
March 6, 2025 -
Automated Text Messaging for Hypertension Gets High Ratings—and Shows why Randomized Controlled Trials are Important
February 4, 2025 -
A National Randomized Trial Seeks to Increase Kidney Transplants. Is it Working?
December 2, 2024 -
Heart Patients Exercised More by Using Games and Incentives To Maintain Money, New Study Showed
August 15, 2024 -
Preventive care is under threat: PrEP now or pay later
July 20, 2024 -
Colorectal Cancer Screening: How to Increase Rates
June 10, 2024 -
Dr Ravi Parikh Presents Groundbreaking BE-a-PAL Data on Default Palliative Care Referrals
June 2, 2024